| Associations of disease-modifying therapies with COVID-19 severity in multiple sclerosis S Simpson-Yap, E De Brouwer, T Kalincik, N Rijke, JA Hillert, C Walton, ... Neurology 97 (19), e1870-e1885, 2021 | 240 | 2021 |
| Symptomatology and symptomatic treatment in multiple sclerosis: Results from a nationwide MS registry PS Rommer, K Eichstädt, D Ellenberger, P Flachenecker, T Friede, ... Multiple Sclerosis Journal 25 (12), 1641-1652, 2019 | 157 | 2019 |
| Multiple sclerosis registries in Europe–An updated mapping survey A Glaser, A Stahmann, T Meissner, P Flachenecker, D Horáková, ... Multiple sclerosis and related disorders 27, 171-178, 2019 | 81 | 2019 |
| Multiple sclerosis registries in Europe–An updated mapping survey A Glaser, A Stahmann, T Meissner, P Flachenecker, D Horáková, ... Multiple sclerosis and related disorders 27, 171-178, 2019 | 81 | 2019 |
| COVID-19 in people with multiple sclerosis: A global data sharing initiative LM Peeters, T Parciak, C Walton, L Geys, Y Moreau, E De Brouwer, ... Multiple Sclerosis (Houndmills, Basingstoke, England), 2020 | 64 | 2020 |
| Chances and challenges of a long-term data repository in multiple sclerosis: 20th birthday of the German MS registry LM Ohle, D Ellenberger, P Flachenecker, T Friede, J Haas, K Hellwig, ... Scientific reports 11 (1), 1-9, 2021 | 45 | 2021 |
| Updated results of the COVID-19 in MS Global Data Sharing Initiative: anti-CD20 and other risk factors associated with COVID-19 severity S Simpson-Yap, A Pirmani, T Kalincik, E De Brouwer, L Geys, T Parciak, ... Neurology-Neuroimmunology Neuroinflammation 9 (6), 2022 | 43 | 2022 |
| Is benign MS really benign? What a meaningful classification beyond the EDSS must take into consideration D Ellenberger, P Flachenecker, J Haas, K Hellwig, F Paul, A Stahmann, ... Multiple Sclerosis and Related Disorders 46, 102485, 2020 | 35 | 2020 |
| Data harmonization for collaborative research among MS registries: a case study in employment A Salter, A Stahmann, D Ellenberger, F Fneish, WJ Rodgers, R Middleton, ... Multiple Sclerosis Journal 27 (2), 281-289, 2021 | 31 | 2021 |
| Relapsing and progressive MS: the sex-specific perspective PS Rommer, D Ellenberger, K Hellwig, J Haas, D Pöhlau, A Stahmann, ... Therapeutic Advances in Neurological Disorders 13, 1756286420956495, 2020 | 31 | 2020 |
| Multiple Sclerosis Data Alliance–A global multi-stakeholder collaboration to scale-up real world data research LM Peeters, T Parciak, D Kalra, Y Moreau, E Kasilingam, P Van Galen, ... Multiple Sclerosis and Related Disorders 47, 102634, 2021 | 22 | 2021 |
| SARS-CoV-2 vaccination in patients with multiple sclerosis in Germany and the United Kingdom: Gender-specific results from a longitudinal observational study N Frahm, F Fneish, D Ellenberger, J Haas, M Loebermann, T Parciak, ... The Lancet Regional Health-Europe 22, 100502, 2022 | 21 | 2022 |
| Epilepsy as a predictor of disease progression in multiple sclerosis M Grothe, D Ellenberger, F von Podewils, A Stahmann, PS Rommer, ... Multiple Sclerosis Journal, 13524585211046739, 2021 | 20 | 2021 |
| First results of the COVID-19 in MS Global Data Sharing Initiative suggest anti-CD20 DMTs are associated with worse COVID-19 outcomes S Simpson-Yap, E De Brouwer, T Kalincik, N Rijke, J Hillert, C Walton, ... Multiple Sclerosis Journal, 48-49, 2020 | 20 | 2020 |
| Effect of applying inclusion and exclusion criteria of phase III clinical trials to multiple sclerosis patients in routine clinical care KO Jalusic, D Ellenberger, P Rommer, A Stahmann, U Zettl, K Berger Multiple Sclerosis Journal 27 (12), 1852-1863, 2021 | 18 | 2021 |
| Trends in administrative prevalence of multiple sclerosis and utilization patterns of disease modifying drugs in Germany J Holstiege, MK Akmatov, K Klimke, L Dammertz, C Kohring, C Marx, ... Multiple Sclerosis and Related Disorders, 103534, 2022 | 17 | 2022 |
| Multiple sclerosis in Germany: updated analysis of the German MS Registry 2014-2018 P Flachenecker, K Eichstädt, K Berger, D Ellenberger, T Friede, J Haas, ... Fortschritte der Neurologie-Psychiatrie 88 (7), 436-450, 2020 | 15 | 2020 |
| Aggressive multiple sclerosis-a matter of measurement and timing D Ellenberger, P Flachenecker, F Fneish, N Frahm, K Hellwig, F Paul, ... Brain, awaa306, 2020 | 14 | 2020 |
| Management of MS patients treated with daclizumab-a case series of 267 patients PS Rommer, K Berger, D Ellenberger, F Fneish, A Simbrich, A Stahmann, ... Frontiers in Neurology 11, 996, 2020 | 14 | 2020 |
| Neuroimmunological registries in Germany S Thiel, F Leypoldt, L Röpke, KP Wandinger, T Kümpfel, O Aktas, ... Neurology international open 2 (01), E25-E39, 2018 | 13 | 2018 |
Christoph KleinschnitzProfessor für NeurologieVerified email at uni-wuerzburg.de
